Tumour biomarker expression relative to age and molecular subtypes of invasive breast cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/bjc2012219.pdf
Reference34 articles.
1. Aebi S, Gelber S, Castogione-Gertsch M, Gelber RD, Collins J, Thürlimann B, Rudenstam CM, Lindtner J, Crivellari D, Cortes-Funes H, Simoncini E, Werner ID, Coates AS, Goldhirsch A (2000) Is chemotherapy alone adequate for young women with oestrogen receptor positive breast cancer? Lancet 355: 1869–1874
2. Agrup M, Stal O, Olsen K, Wingren S (2002) C-erb-2 over-expression and survival in early onset breast cancer. Breast Can Res Treat 63: 23–29
3. Ahn SJ, Son BH, Kim SW, Kim SI, Jeong J, Ko SS, Han W, Korean Breast Cancer Society (2007) Poor outcome of hormone receptor-positive breast cancer at very young age Is due to tamoxifen resistance: nationwide survival data in Korea – a report from the Korean Breast Cancer Society. J Clin Oncol 25: 2360–2368
4. Anders CK, Hsu DS, Broadwater G, Acharya CR, Foekens JA, Zhang Y, Wang Y, Marcom PK, Marks JR, Febbo PG, Nevins JR, Potti A, Blackwell KL (2008) Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol 26: 3324–3330
5. Anders CK, Johnson R, Litton J, Phillips M, Bleyer A (2009) Breast cancer before age 40 years. Semin Oncol 36: 237–249
Cited by 79 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Association of imaging and pathological findings of breast cancer in very young women: Report of a twenty-year retrospective study;Clinical Imaging;2024-06
2. Age‐related phenotypes in breast cancer: A population‐based study;International Journal of Cancer;2024-02-06
3. Survival and Trends in Annualized Hazard Function by Age at Diagnosis Among Chinese Breast Cancer Patients Aged ≤40 Years: Case Analysis Study;JMIR Public Health and Surveillance;2023-07-18
4. Assessing the Utility of a Proposed System for Routine Assessment of Tumour Budding in Core Biopsies of Breast Cancer, a Robust Adjunct to Conventional Grading to Improve Prediction of Stage, Response to Neoadjuvant Chemotherapy and Prognosis;2023-06-09
5. Genomics of ERBB2-Positive Breast Cancer in Young Women Before and After Exposure to Chemotherapy Plus Trastuzumab;JCO Precision Oncology;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3